This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Abbott BD, Birnbaum LS (1989) TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicol Appl Pharmacol 99:276–286
Abbott BD, Birnbaum LS (1991) TCDD exposure of human embryonic palatal shelves in organ culture alters the differentiation of medial epithelial cells. Teratology 43:119–132
Abbott BD, Harris MW, Birnbaum LS (1992) Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology 45:35–53
Ahlborg UG, Brouwer A, Fingerhut MA, Jacobson JL, Jacobson SW, Kennedy SW, Kettrup AAF, Koeman JH, Poiger H, Rappe C, Safe SH, Seegal RF, Tuomisto J, Van den Berg M (1992) Impact of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphyenyls on human and environmental health, with special emphasis on application of the toxic equivalency factor concept. Eur J Pharmacol 228:179–199
Ahlborg UG, Becking GC, Birnbaum LS, Brouwer A, Derks HJGM, Feeley M, Golor G, Hanberg A, Larsen JC, Liem AKD, Safe SH, Schlatter C, Wærn F, Younes M, Yrjänheikki E (1994) Toxic equivalency factors for dioxin-like PCBs. Chemosphere 28:1049–1067
Anttila S, Hietanen E, Vainio H, Camus A-M, Gelboin HV, Park SS, Heikkila L, Karjalainen A, Bartsch H (1991) Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P4501A1 in lung cancer patients. Int J Cancer 47:681–685
Bale AE, Nebert DW, McBride OW (1987) Subchromosomal localization of the dioxin-inducible P1450 locus (CYP1) and description of two RFLPs detected with a 3′P1450 cDNA probe. Cytogenet Cell Genet 46:574–575
Banbury Report 35 (1991) Biological basis for risk assessment of dioxins and related compounds. Gallo MA, Scheuplein RJ, van der Heijden KA (eds.). Cold Spring Harbor Laboratory Press
Bayney RM, Morton MR, Favreau LV, Pickett CB (1989) Rat liver NAD (P) H: quinone reductase. J Biol Chem 264:21793–21797
Beck H, Eckart K, Mathar W, Wittkowski R (1989a) PCDD and PCDF body burden from food intake in the Federal Republic of Germany. Chemosphere 18:417–424
Beck H, Eckart K, Mathar W, Wittkowski R (1989b) Dependence of PCDD and PCDF levels in human milk on various parameters in the Federal Republic of Germany. Chemosphere 18:1063–1066
Beck H, Droß A, Kleemann WJ, Mathar W (1990) PCDD and PCDF concentrations in different organs from infants. Chemosphere 20:903–910
Berghard A, Gradin K, Pongratz I, Whitelaw M, Poellinger L (1993) Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism. Mol Cell Biol 13:677–689
Birnbaum LS (1991) Developmental toxicity of TCDD and related compounds: species sensitivities and differences. Banbury Report 35 (1991) Biological Basis for Risk Assessment of Dioxins and Related Compounds. Gallo MA, Scheuplein RJ, van der Heijden KA (eds.). Cold Spring Harbor Laboratory Press, pp. 51–64
Bjeldanes LF, Kim J-Y, Grose KR, Bartholomew JC, Bradfield CA (1991) Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 88:9543–9547
Blaylock BL, Holladay SD, Comment CE, Heindel JJ, Luster MI (1992) Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol Appl Pharmacol 112:207–213
Bock KW (1991) Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. CRC Crit Rev Biochem Mol Biol 26:129–150
Bock KW, Wiltfang J, Blume R, Ullrich D, Bircher J (1987) Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking. Eur J Clin Pharmacol 31:677–6830
Bock KW, Lipp HP, Bock-Hennig BS (1990) Induction of drug-metabolizing enzymes by xenobiotics. Xenobiotica 20:1101–1111
Bock KW, Gschaidmeier H, Seidel A, Baird S, Burchell B (1992) Mono-and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1). Mol Pharmacol 42:613–618
Bock KW, Forster A, Gschaidmeier H, Brück M, Münzel P, Schareck W, Fournel-Gigleux S, Burchell B (1993) Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol 45:1809–1814
Bock KW, Schrenk D, Forster A, Griese E-U, Mörike K, Brockmeier D, Eichelbaum M (1994) The influence of environmental and genetic factors on CYP2D6, CYP1A2, and UDP-glucuronosyl transferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics, (in press)
Bradfield CA, Poland A (1988) A competitive binding assay for 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands of the Ah receptor. Mol Pharmacol 34:682–688
Bradfield CA, Glover E, Poland A (1991) Purification and N-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse. Mol Pharmacol 39:13–19
Burbach KM, Poland A, Bradfield CA (1992) Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci USA 89:8185–8189
Burchell B, Nebert DW, Nelson DR, Bock KW, Iyanagi T, Jansen PLM, Lancet D, Mulder GJ, Roy Chowdhury J, Siest G, Tephly TR, Mackenzie PI (1991) The UDP glucuronosyltransferase gene superfamily. Suggested nomenclature based on evolutionary divergence. DNA Cell Biol 10:487–494
Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF (1989) Human cytochrome P-450PA (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86:7696–7700
Buu-Hoï NP, Chanh P-H, Sesqué G Azum-Gelade MC, Saint-Ruf G (1972) Organs as targets of ‘dioxin’ (2,3,7,8-tetrachlorodibenzo-p-dioxin) intoxication. Naturwissenschaften 59:174–175
Byard JL (1987) The toxicological significance of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds in human adipose tissue. J Toxicol Environ Health 22:381–403
Campbell ME, Spielberg SP, Kalow W (1987) A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 42:157–165
Carlstedt-Duke JMB (1979) Tissue distribution of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Cancer Res 39:3172–3176
Carrier F, Owens RA, Nebert DW, Puga A (1992) Dioxin-dependent activation of murine Cypla-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol Cell Biol 12:1856–1863
Chang K-J, Hsieh K-H, Lee T-P, Tang S-Y, Tung T-C (1981) Immunologic evaluation of patients with polychlorinated biphenyl poisoning: determination of lymphocyte subpopulations. Toxicol Appl Pharmacol 61:58–63
Chang K-J, Hsieh K-H, Tang S-Y, Tung T-C, Lee T-P (1982) Immunologic evaluation of patients with polychlorinated biphenyl poisoning: evaluation of delayed-type skin hypersensitivity response and its relation to clinical studies. J Toxicol Environ Health 9:217–223
Choi EJ, Toscano DG, Ryan JA, Riedel N, Toscano WA jr. (1991) Dioxin induces transforming growth factor-α in human keratinocytes. J Biol Chem 266:9591–9597
Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes memorial lecture. Cancer Res 42:4875–4917
Cook JC, Dold KM, Greenlee WF (1987) An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus. Toxicol Appl Pharmacol 89:256–268
Courtney KD, Moore JA (1971) Teratology studies with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 20:396–403
Cousin E, Medcalf RL, Bergonzelli GE, Kruithof EK (1991) Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 19:3881–3886
Couture-Haws L, Harris MW, Lockhart AC, Birnbaum LS (1991) Evaluation of the persistence of hydronephrosis induced in mice following in utero and/or lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 107:402–412
Denison MS, Fisher JM, Whitlock JP jr. (1989) Protein-DNA interactions at recognition sites for the dioxin-Ah receptor complex. J Biol Chem 264:16478–16482
Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990) Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266–1272
Ema M, Sogawa K, Watanabe N, Chujoh Y, Matsushita N, Gotoh O, Funae Y, Fujii-Kuriyama Y (1992) cDNA cloning and structure of mouse putative Ah receptor. Biochem Biophys Res Commun 184:246–253
Enan E, Liu PCC, Matsumura F (1992) 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig. J Biol Chem 267:19785–19791
Environ Health Persp. (1985) Vol 59
Evans RM (1988) The steroid and thyroid hormone receptor super family. Science 240:889–895
Favreau LV, Pickett CB (1991) Transcriptional regulation of the rat NAD(P)H: quinone reductase gene. J Biol Chem 266:4556–4561
Filler R, Lew KJ (1981) Developmental onset of mixed-function oxidase activity in preimplantation mouse embryos. Proc Natl Acad Sci USA 78:6991–6995
Fine JS, Gasiewicz TA, Silverstone AE (1989) Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 35:18–25
Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, Sweeney MH, Greife AL, Dill PA, Steenland K, Suruda AJ (1991) Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. New England J Med 324:212–218
Fujisawa-Sehara A, Sogawa K, Yamane M, Fujii-Kuriyama Y (1987) Characterization of xenobiotic responsive elements upstream from the drug-metabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements. Nucleic Acids Res 15:4179–4191
Gaido KW, Maness SC, Leonard LS, Greenlee WF (1992) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-α and-β2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J Biol Chem 267:24591–24595
Galloway SM, Perry PE, Meneses J, Nebert DW, Pedersen RA (1980) Cultured mouse embryos metabolize benzo[a]pyrene during early gestation: genetic differences detectable by sister chromatid exchange. Proc Natl Acad Sci USA 77:3524–3528
Gillner M, Bergman J, Cambillau C, Gustafsson J-Å (1980) Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 10:651–654
Gonzalez FJ (1989) The molecular biology of cytochrome P450s. Pharmacol Rev 40:243–288
Greenlee WF, Dold KM, Irons RD, Osborne R (1985a) Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicol Appl Pharmacol 79:112–120
Greenlee WF, Dold KM, Osborne R (1985b) Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture. In Vitro Cell Develop Biol 21:509–512
Greenlee WF, Sutter TR, Marcus C (1993) Molecular basis of dioxin actions on rodent and human target tissues. Clin Biol Res (in press)
Hagenmaier H, Kraft M, Brunner H, Haag R (1987) Catalytic effects of fly ash from waste incineration facilities on the formation and decomposition of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans. Environ Sci Technol 21:1080–1084
Hahn ME, Stegeman JJ (1992) Phylogenetic distribution of the Ah receptor in nonmammalian species: implications for dioxin toxicity and Ah receptor evolution. Chemosphere 25:931–937
Harding D, Fournel-Gigleux S, Jackson MR, Burchell B (1988) Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc Natl Acad Sci USA 85:8381–8385
Haugen A, Willey J, Borresen AL, Tefre T (1990) Pst I polymorphism at the human P1450 gene on chromosome 15. Nucleic Acids Res 18:3114
Hébert CD, Cao Q-L, Birnbaum LS (1990) Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Carcinogenesis 11:1335–1342
Helferich WG, Denison MS (1991) Ultraviolet photoproducts of tryptophan can act as dioxin agonists. Mol Pharmacol 40:674–678
Hempel J, Harper K, Lindahl R (1989) Inducible (Class 3) aldehyde dehydrogenase from rat hepatocellular carcinoma and 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated liver: distant relationship to the class 1 and 2 enzymes from mammalian liver cytosol/mitochondria. Biochemistry 28:1160–1167
Henck JW, New MA, Kociba RJ, Rao KS (1981) 2,3,7,8-tetrachlorodibenzo-p-dioxin: acute oral toxicity in hamsters. Toxicol Appl Pharmacol 59:405–407
Hoffman EC, Reyes H, Chu F-F, Sander F, Conley LH, Brooks BA, Hankinson O (1991) Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252:954–958
Holsapple MP, Snyder NK, Wood SC, Morris DL (1991) A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology 69:219–255
Hsu LC, Chang W-C, Shibuya A, Yoshida A (1992) Human stomach aldehyde dehydrogenase cDNA and genomic cloning, primary structure, and expression in Escherichia coli. J Biol Chem 267:3030–3037
Jaiswal AK (1991) Human NAD(P)H: quinone oxidoreductase (NQO1) gene structure and induction by dioxin. Biochemistry 30:10647–10653
Jaiswal AK, Gonzalez J, Nebert DW (1985) Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo(a)pyrene metabolism. Nucleic Acids Res 13:4503–4520
Jaiswal AK, McBride OW, Adesnik M, Nebert DW (1988) Human dioxin-inducible cytosolic NAD(P)H: menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. J Biol Chem 263:13572–13578
Jansen PLM, Mulder GJ, Burchell B, Bock KW (1992) New developments in glucuronidation research: report of a workshop on “Glucuronidation, its role in health and disease”. Hepatology 15:532–544
Kadlubar FF, Butler MA, Kaderlik KR, Chou H-C, Lang NP (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 98:69–74
Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263:131–133
Kellermann G, Shaw CR, Luyten-Kellermann M (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. New England J Med 289:934–937
Kerkvliet NI, Steppan LB, Brauner JA, Deyo JA, Henderson MC, Tomar RS, Buhler DR (1990) Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression. Toxicol Appl Pharmacol 105:26–36
Kimming J, Schultz K (1957) Chlorinated aromatic cyclic esters as the cause of chloracne. Naturwissenschaften 44:337–338
Kimura S, Gonzalez FJ, Nebert DW (1986) Tissue-specific expression of the mouse dioxin-inducible P1450 and P3450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues. Mol Cell Biol 6:1471–1477
Kimura S, Smith HH, Hankinson O, Nebert DW (1987) Analysis of two benzo(a)pyrene-resistant mutants of the mouse hepatoma Hepa-1, P1-450 via cDNA expression in yeast. EMBO J 6:1929–1933
Kleman M, Övervik E, Mason G, Gustafsson J-Å (1990) Effects of the food mutagens MeIQx and PhIP on the expression of cytochrome P450IA proteins in various tissues of male and female rats. Carcinogenesis 11:2185–2189
Knutsen AP (1984) Immunologic effects of TCDD exposure in humans. Bull Environ Contam Toxicol 33:673–681
Knutson JC, Poland A (1984a) Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-p-dioxin: interaction of the Ah and hr loci. Cell 30:225–234
Knutson JC, Poland A (1984b) 2,3,7,8-tetrachlorodibenzo-p-dioxin: examination of biochemical effects involved in the proliferation and differentiation of XB cells. J Cell Physiol 121:143–151
Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Barnard SD, Hummel RA, Humiston CG (1978) Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46:279–303
Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Research 42:5030–5037
Kunstadter P (1982) A study of herbicides and birth defects in the Republic of Vietnam. An analysis of hospital records. National Academy Press, Washington, D.C.
Kutz FW, Barnes DG, Bretthauer EW, Bottimore DP, Greim H (1990) The international toxicity equivalency factor (I-TEF) method for estimating risks associated with exposures to complex mixtures of dioxins and related compounds. Toxicol Environ Chem 26:99–109
Landers JP, Bunce NJ (1991) The Ah receptor and the mechanism of dioxin toxicity. Biochem J 276:273–287
Legraverend C, Harrison DE, Ruscetti FW, Nebert DW (1983) Bone marrow toxicity induced by oral benzo(a)pyrene: protection resides at the level of the intestine and liver. Toxicol Appl Pharmacol 70:390–401
Lin FH, Clark G, Birnbaum LS, Lucier GW, Goldstein JA (1991a) Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor. Mol Pharmacol 39:307–313
Lin FH, Stohs SJ, Birnbaum LS, Clark G, Lucier GW, Goldstein JA (1991b) The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicol Appl Pharmacol 108:129–139
Lipp H-P, Schrenk D, Wiesmüller T, Hagenmaier H, Bock KW (1992) Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and their constituents in human HepG2 cells. Arch Toxicol 66:220–223
Lucier GW, Nelson KG, Everson RB, Wong TK, Philpot RM, Tiernan T, Taylor M, Sunahara GI (1987) Placental markers of human exposure to polychlorinated biphenyls and polychlorinated dibenzofurans. Environ Health Perspect 76:79–87
Lucier GW, Sunahara GI, Wong TK (1990) Placental markers of human exposure to polychlorinated dibenzofurans and polychlorinated biphenyls: implications for risk assessment. In: Vainio H, Sorsa M, McMichael AJ (eds) Complex mixtures and cancer risk. World Health Organization. International Agency for Research on Cancer, Lyon pp 55–62 (IARC Scientific Publications No. 104)
Lucier GW, Tritscher A, Goldsworthy T, Foley J, Clark G, Goldstein J, Maronpot R (1991) Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res 51:1391–1397
Luebeck EG, Moolgavkar SH, Buchmann A, Schwarz M (1991) Effects of polychlorinated biphenyls in rat liver: quantitative analysis of enzyme-altered foci. Toxicol Appl Pharmacol 111:469–484
Lusska A, Shen E, Whitlock JP jr. (1993) Protein-DNA interactions at a dioxin-responsive enhancer. J Biol Chem 286:6575–6580
Luster MI, Germolec DR, Clark G, Wiegand G, Rosenthal GJ (1988) Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J Immunol 140:928–935
Ma X, Mufti NA, Babish JG (1992) Protein tyrosine phosphorylation as an indicator of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in vivo and in vitro. Biochem Biophys Res Commun 189:59–65
Mastroiacovo P, Spagnolo A, Marni E, Meazza L, Bertollini R, Segni G (1988) Birth defects in the Seveso area after TCDD contamination. J Am Med Assoc (JAMA) 259:1668–1672
McConkey DJ, Hartzell P, Duddy SK, Hakansson H, Orrenius S (1988) 2,3,7,8-tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca++-mediated end-onuclease activation. Science 242:256–259
McConnell EE, Moore JA, Haseman JK, Harris MW (1978) The comparative toxicity of chlorinated dibenzo-p-dioxins in mice and guinea pigs. Toxicol Appl Pharmacol 44:335–356
McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, Eggleston JC, Boyd MR, Hines RN (1990) Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 82:1333–1339
Mocarelli P, Needham LL, Marocchi A, Patterson DG jr., Brambilla P, Gerthoux PM, Meazza L, Carrieri V (1991) Serum concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin and test results from selected residents of Seveso, Italy. J Toxicol Environ Health 32:357–366
Moolgavkar SH (1989) Multistage models form cancer risk assessment. In: Travis CT (ed) Biologically based methods for cancer risk assessment. Plenum Press, New York pp 9–20
Mucklow JC, Fraser HS, Bulpitt CJ, Kahn C, Mould G, Dolery CT (1980) Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmacol 10:67–74
Münzel PA, Brück M, Bock KW, Owens IS, Ritter JK (1994) Transcriptional regulation of the human phenol UDP-glucuronosyl transferase (UGT1*6) gene in the A549 lung carcinoma cell line. Naunyn-Schmiedeberg's Arch Pharmacol 349:R103
Muto H, Takizawa Y (1989) Dioxins in cigarette smoke. Arch Environ Health 44:171–174
Nagarkatti PS, Sweeney GD, Gauldie J, Clark DA (1984) Sensitivity to suppression of cytotoxic T cell generation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on the Ah genotype of the murine host. Toxicol Appl Pharmacol 72:169–176
Nambu JR, Lewis JO, Wharton KA jr., Crews ST (1991) The Drosophila single-minded gene encodes a helix-loop-helix protein that acts as a master regulator of CNS midline development. Cell 67:1157–1167
Nato/CCMS (1988) Committee on the Challenges of Modern Society. Scientific basis for the international toxicity equivalency factor (I-TEF) method of risk assessment for complex mixtures. Pilot Study on International Information Exchange on Dioxins and Related Compounds. North Atlantic Treaty Organization (NATO), CCMS Report No. 178.
Nebert DW (1980) The Ah locus. A gene with possible importance in cancer predictability. Arch Toxicol Suppl 3:195–207
Nebert DW (1991) Proposed role of drug-metabolizing enzymes: Regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol 5:1203–1214
Nebert DW, Gonzalez FJ (1987) P450 genes: structure, evolution and regulation. Annu Rev Biochem 56:945–993
Nebert DW, Jones JE (1989) Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. Int J Biochem 21:243–252
Nebert DW, Goujon JE, Gielen JE (1972) Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. Nature New Biol 235:107–110
Nebert DW, Nelson DR, Feyereisen R (1989) Evolution of the cytochrome P450 genes. Xenobiotica 19:1149–1160
Nebert DW, Petersen DD, Fornace AJ jr. (1990) Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. Environ Health Perspect 88:13–25
Nebert DW, Petersen DD, Puga A (1991) Human AH locus polymorphism and cancer. Inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics 1:68–78
Neubert D, Zens P, Rothenwallner A, Merker HJ (1973) A survey of the embryotoxic effects of TCDD in mammalian species. Environ Health Perspect 5:67–79
Okey AB (1990) Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45:241–298
Okey AB, Vella LM, Harper PA (1989) Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methyl-cholanthrene. Mol Pharmacol 35:823–830
Okino ST, Pendurthi UR, Tukey RH (1993) 2,3,7,8-tetrachlorodibenzo-p-dioxin induces the nuclear translocation of two XRE binding proteins in mice. Pharmacogenetics 3:101–109
Olson JR, Holscher MA, Neal RA (1980) Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the golden Syrian hamster. Toxicol Appl Pharmacol 55:67–78
Owens IS (1977) Genetic regulation of UDP-glucuronosyltransferase induction by polycyclic aromatic compounds in mice. J Biol Chem 252:2827–2833
Owens IS, Ritter JK (1992) The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus: implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes. Pharmacogenetics 2, 93–108
Paulson KE, Darnell JE jr., Rushmore T, Pickett CB (1990) Analysis of the upstream elements of the xenobiotic compound-inducible and positionally regulated glutathione S-transferase Ya gene. Mol Cell Biol 10:1841–1852
Perdew GH (1988) Association of the Ah receptor with the 90-kDA heat shock protein. J Biol Chem 263:13802–13805
Perdew GH (1992) Chemical cross-linking of the cytosolic and nuclear forms of the Ah receptor in hepatoma cell line 1c1c7. Biochem Biophys Res Commun 182:55–62
Perdew GH, Hollenback CE (1990) Analysis of photoaffinity-labeled aryl hydrocarbon receptor heterogeneity by two-dimensional gel electrophoresis. Biochemistry 29:6210–6214
Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, McBride OW, Nebert DW (1991) Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48:720–725
Piper WN, Rose JQ, Gehring PJ (1973) Excretion and tissue distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat. Environ Health Perspect 5:241–244
Pirkle JL, Wolfe WH, Patterson DG, Needham LL, Michalek JE, Miner JC, Peterson MR, Phillips DL (1989) Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam veterans of Operation Ranch Hand. J Toxicol Environ Health 27:165–171
Pitot HC, Goldsworthy T, Campbell HA, Poland A (1980) Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res 40:3616–3620
Pocchiary F, Silano V, Zampieri A (1979) Human health effects from accidental release of tetrachlorodibenzo-p-dioxin at Seveso, Italy, Ann N. Y. Acad Sci 320:311–320
Poellinger L, Wilhelmsson A, Cuthill S, Pongratz I, Mason GGF, Gustafsson J-Å (1991) Modulation of dioxin receptor function by protein-protein interaction. Banbury Report 35 (1991) Biological basis for risk assessment of dioxins and related compounds. Gallo MA, Scheuplein RJ, van der Heijden KA (eds.). Cold Spring Harbor Laboratory Press, pp. 311–319
Pohjanvirta R, Tuomisto J, Vartiainen, Rozman K (1987) Han/Wistar rats are exceptionally resistant to TCDD. J Pharmacol Toxicol 60:145–150
Poiger H, Schlatter C (1986) Pharmacokinetics of 2,3,7,8-TCDD in man. Chemosphere 15:1489–1494
Poland A, Glover E (1979) An estimate of the maximum in vivo covalent binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to rat liver protein, ribosomal RNA, and DNA. Cancer Res 39:3341–3344
Poland A, Glover E (1980) 2,3,7,8-Tetrachlorodibenzo-p-dioxin: segregation of toxicity with the Ah locus. Mol Pharmacol 17:86–94
Poland A, Knutson JC (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22:517–554
Poland A, Glover E (1990) Characterization and strain distribution pattern of the murine Ah receptor specified by the Ahd and AHb−3 alleles. Mol Pharmacol 38:306–312
Poland A, Glover E, Robinson JR, Nebert DW (1974) Genetic expression of aryl hydrocarbon hydroxylase activity: induction of monooxygenase activities and cytochrome P-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically ‘nonresponsive’ to other aromatic hydrocarbons. J Biol Chem 249:5599–5606
Poland A, Glover E, Kende AS (1976) Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. J Biol Chem 251:4936–4946
Poland A, Palen D, Glover E (1982) Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature 300:271–273
Poland A, Glover E, Bradfield C (1991) The Ah receptor: characterization, purification and preparation of polyclonal antibodies. In: Bock KW, Gerok W, Matern S, Schmid R (eds) Hepatic metabolism and disposition of endo-and xenobiotics. Kluwer Academic Publishers, Dordrecht, Boston, London, pp 109–114
Pongratz I, Strömstedt P-E, Mason GGF, Poellinger L (1991) Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J Biol Chem 266:16813–16817
Prochaska HJ, Talalay P (1988) Regulatory mechanisms of mono-functional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res 48:4776–4782
Puga A, Nebert DW, Carrier F (1992) Dioxin induces expression of c-fos and c-jun protooncogenes and a large increase in transcription factor AP-1. DNA Cell Biol 11:269–281
Quattrochi LC, Tukey RH (1989) The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene. Mol Pharmacol 36:66–71
Quattrochi LC, Tukey RH (1993) Nuclear uptake of the AH (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene. Mol Pharmacol 43:504–508
Rannug A, Rannug U, Rosenkranz HS, Winqvist L, Westerholm R, Agurell E, Grafström A-K (1987) Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J Biol Chem 262:15422–15427
Rattner BA, Hoffman DJ, Marn CM (1989) Use of mixed-function oxygenases to monitor contaminant exposure in wildlife. Environ Toxicol Chem 8:1093–1102
RayChaudhuri B, Nebert DW, Puga A (1990) The murine Cyp1a-1 gene negatively regulates its own transcription and that of other members of the aromatic hydrocarbon-responsive [Ah] gene battery. Mol Endocrin 4:1773–1781
Reggiani G (1978) Medical problems raised by a TCDD contamination in Seveso, Italy. Arch Toxicol 40:161–188
Reggiani G (1989) The Seveso accident: medical survey of a TCDD exposure. In: Kimbrough R, Jensen A (eds.). Halogenated biphenyls, terphenyls, naphthalenes, dibenzodioxins and related products. Elsevier Science Publishers, New York, pp. 445–470
Reyes H, Reisz-Porszasz S, Hankinson O (1992) Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256:1193–1195
Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P (1990) Growth factor control of extracellular proteolysis. Cell Differentiation Dev 32:313–318
Robertson JA, Nebert DW, Hankinson O (1987) Autoregulation plus positive and negative elements controlling transcription of genes in the [Ah] battery. Chem Scr 27A:83–87
Rogan WJ, Gladen BC, Hung KL, Koong SL, Shih LY, Taylor JS, Wu YC, Yang D, Ragan NB, Hsu, CC (1988) Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 241:334–336
Rose JQ, Ramsey JC, Wentzler TH, Hummel RA, Gehring PJ (1976) The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat. Toxicol Appl Pharmacol 36:209–226
Rozman K, Rozman T, Greim H (1984) Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity. Toxicol Appl Pharmacol 72:372–376
Rushmore TH, Pickett CB (1990) Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. J Biol Chem 265:14648–14653
Safe SH (1986) Comparative toxicology and mechanism of action of poychlorinated dibenzo-p-dioxins and dibenzofurans. Annu Rev Pharmacol Toxicol 26:371–399
Safe S, Astroff B, Zacharewski T, Dickerson R, Romkes M, Biegel L (1991) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antiestrogens: characterization and mechanism of action. Pharmacol Toxicol 69:400–409
Schecter A (1991) Dioxins and related chemicals in humans and in the environment. In: Gallo MA, Scheuplein RJ, van der Heijden K, (eds) Banbury Report 35: Biological basis of risk assessment of dioxins and related compounds. Cold Spring Harbor Laboratory Press, America, pp 169–212
Schieback S, Münzel PA, Bock-Hennig BS, Bock KW (1994) TCDD-inducible expression of c-Jun and c-Fos in hepatocyte primary cultures. Naunyn-Schmiedeberg's Arch Pharmacol 349: R115
Schlatter C (1991) Data on kinetics of PCDDs and PCDFs as a prerequisite for human risk assessment. In: Gallo MA, Scheuplein RJ, van der Heijden K (eds) Banbury Report 35: Biological basis for risk assessment of dioxins and related compounds. Cold Spring Harbor Laboratory Press, America, pp 215–226
Schrenk D, Lipp HP, Brunner H, Wiesmüller T, Hagenmaier H, Bock KW (1991a) Induction of hepatic P450-dependent monooxygenase in feral mice from PCDD/PCDF-contaminated area. Chemosphere 22:1011–1018
Schrenk D, Lipp HP, Wiesmüller T, Hagenmaier H, Bock KW (1991b) Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins: comparison between defined mixtures and their constituents. Arch Toxicol 65:114–118
Schrenk D, Karger A, Lipp HP, Bock KW (1992) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and ethinylestradiol as co-mitogens in cultured rat hepatocytes. Carcinogenesis 13:453–456
Schrenk D, Buchmann A, Dietz K, Lipp H-P, Brunner H, Sirma H, Münzel P, Hagenmaier H, Gebhardt R, Bock KW (1994) Promotion of preneoplastic foci of rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins Carcinogenesis 15:509–515
Schrenk D, Schäfer S, Bock KW (1994) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) as growth modulator in mouse hepatocytes high-and low-affinity with Ah receptor. Carcinogenesis 15:27–31
Schwetz BA, Norris JM, Sparschu GK, Rowe VK, Gehring PJ, Emerson JL, Gesbig CG (1973) Toxicology of chlorinated dibenzo-p-dioxins. Environ Health Perspect 5:87–99
Seefeld MD, Corbett SW, Keesey RE, Peterson RE (1984) Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 73:311–322
Sies H (1991) Oxidative stress: from basic research to clinical application. Am J Med 91 (suppl. 3C):31S–38S
Skene SA, Dewhurst IC, Greenberg M (1989) Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans: the risks to human health. A review. Human Toxicol 8:173–203
Soderkvist P, Poellinger L, Toftgard R, Gustafsson J-Å (1988) Differential expression of the cytochrome P-450c and P-450d genes in the rat ventral prostate and liver. Cancer Res 48:3045–3049
Spurr NK, Gough AC, Stevenson K, Wolf CR (1987) Msp-I polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res 15:5901
Stegeman JJ, Lech JJ (1991) Cytochrome P-450 monooxygenase systems in aquatic species: carcinogen metabolism and biomarkers for carcinogen and pollutant exposure. Environ Health Perspect 90:101–109
Stehr-Green PA, Naylor PH, Hoffman RE (1989) Diminished thymosin-α1 levels in persons exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Toxicol Environ Health 28:285
Sutter TR, Greenlee WF (1992a) Identification of a human dioxin-responsive cDNA (clone 1) as a new member of the cytochrome P450 superfamily. Dioxin 1992. Finnish Institute of Occupational Health, Helsinki 1992, pp 221–224
Sutter TR, Greenlee WF (1992b) Classification of members of the Ah gene battery. Chemosphere 25:223–226
Sutter TR, Guzman K, Dold KM, Greenlee WF (1991) Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1ß. Science 254:415–418
Takimoto K, Lindahl R, Pitot HC (1992) Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of aldehyde dehydrogenase in hepatoma cells. Arch Biochem Biophys 298:492–497
Tefre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brogger A, Borresen A-L (1991) Human CYP1A1 (cytochrome P1450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1:20–25
Tognoni G, Bonaccorsi A (1982) Epidemiological problems with TCDD (a critical view) Drug Metab Rev 13:447–469
Tucker AN, Vore SJ, Luster MI (1986) Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Mol Pharmacol 29:372–377
Vasiliou V, Puga A, Nebert DW (1992) Negative regulation of the murine cytosolic aldehyde dehydrogenase-3 (Aldh-3c) gene by functional CYP1A1 and CYP1A2 proteins. Biochem Biophys Res Commun 187:413–419
Vos JG, van Loveren H, Schuurman H-J (1991) Immunotoxicity of dioxin: immune function and host resistance in laboratory animals and humans. In: Gallo MA, Scheuplein RJ, van der Heijden KA (eds) Banbury Report 35: Biological basis for risk assessment of dioxins and related compounds. Cold Spring Harbor Laboratory Press, pp. 79–88
Wang X, Narasimhan TR, Morrison V, Safe S (1991) In situ and in vitro photoaffinity labeling of the nuclear aryl hydrocarbon receptor from transformed rodent and human cell lines. Arch Biochem Biophys 287:186–194
Wattenberg LW (1992) Inhibition of carcinogenesis by minor dietary constituents. Cancer Res (Suppl) 52:2085s–2091s
Weber LWD, Lebofsky M, Stahl BU, Gorski JR, Muzi G, Rozman K (1991) Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology 66:133–144
Whitlock JP (1990) Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol 30:251–277
WHO (1989) In: Yrjänheikki EJ (ed) Levels of PCBs, PCDDs and PCDFs in breast milk. FADL Publisher, Copenhagen
Wilhelmsson A, Cuthill S, Denis M, Wikström A-C, Gustafsson J-Å, Poellinger L (1990) The specific DNA binding activity of the dioxin receptor is modulated by the 90 kd heat shock protein. EMBO J 9:69–76
Williams RT (1947) Detoxication mechanisms. Wiley, New York, p. 2
Wölfle D, Münzel P, Fischer G, Bock KW (1988) Altered growth control of rat hepatocytes after treatment with 3,4,3',4'-tetrachlorobiphenyl in vivo and in vitro. Carcinogenesis 9:919–924
Wölfle D, Becker E, Schmutte C (1993) Growth stimulation of primary rat hepatocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cell Biol Toxicol 9:15–31
Wuthe J, Link B, Walther J, Päpke O, Hagenmaier H, Frommberger R, Lillich W, Rack J (1992) Dioxin and furan (PCDD/PCDF) levels in human blood from persons living in a contaminated area. In: Dioxin 1992, Finnish Institute of Occupational Health, Helsinki 1992 pp. 339–342
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag
About this chapter
Cite this chapter
Bock, K.W. (1993). Aryl hydrocarbon or dioxin receptor: Biologic and toxic responses. In: Reviews of Physiology, Biochemistry and Pharmacology, Volume 125. Reviews of Physiology, Biochemistry and Pharmacology, vol 125. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0030908
Download citation
DOI: https://doi.org/10.1007/BFb0030908
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-57930-4
Online ISBN: 978-3-540-48388-5
eBook Packages: Springer Book Archive